The immune system of pregnant women fluctuate throughout the course of the nine months carrying the child or children, this is an established fact. However, the sex of the baby as the factor has always been more of conjecture than anything else. A new study states that this isn’t the case at all and that the sex of the baby does determine the immunity of the mother.
During pregnancy, it’s normal for women to experience several changes that affect their mood, their physical attributes, and their habits. This is only to be expected since the fluctuating hormones are causing havoc in their systems. As far as their immunity goes, Ohio State University Wexner Medical Center researchers recently discovered that women carrying female fetuses tend to be more prone to inflammation, MedicalXpress reports.
According to Amanda Mitchell, one of the researchers behind the study, their research involved looking into the cases of 80 pregnant women. The tests involved measuring the levels of cytokine in their blood as well as their immune cells.
"While women didn't exhibit differences in blood cytokine levels based on fetal sex, we did find that the immune cells of women carrying female fetuses produced more pro-inflammatory cytokines when exposed to bacteria,” Mitchell said. “This means that women carrying female fetuses exhibited a heightened inflammatory response when their immune system was challenged, compared to women carrying male fetuses."
This can be a huge concern because inflammation can add stress to an already strained body, Tech Times notes. The system of a pregnant subject regularly undergoes several transitions that are normally alien. If inflammation persists, it could harm both the mother and the baby.
On that note, Mitchell added that inflammation can be easily managed by sticking to routine habits that are often encouraged by doctors. With proper exercise, a healthy diet full of leafy vegetables and fruits, and frequent meditation, inflammation can be managed.


Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
China vs. NASA: The New Moon Race and What's at Stake by 2030
The four types of dementia most people don’t know exist
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



